MPPE1 and cancer: Because cDC1 are the rarest subset of Ag presenting cells in tumors (30) and their numbers have been shown to decrease in the course of certain immunotherapies (86), strategies aiming at harnessing their functions for cancer treatment should include methods to promote their expansion in vivo.